eQTL mapping in transgenic alpha-synuclein carrying Caenorhabditis elegans recombinant inbred line
Yuqing HuangiD, Yiru A. WangiD, Lisa van SluijsiD, Demi H. J. VogelsiD, Yuzhi CheniD, Vivian I. P. TegelbeckersiD, Steven SchoonderwoerdiD, Joost A. G. RikseniD, Jan E. KammengaiD, Simon Crawford HarveyiD, Mark G. SterkeniD
Abstract
Protein aggregation of -synuclein (S) is a genetic and neuropathological hallmark of Parkinsons disease (PD). Studies in the model nematode Caenorhabditis elegans suggested that variation of S aggregation depends on the genetic background. However, which genes and genetic modifiers underlie individual differences in S pathology remains unknown. To study the genotypic-phenotypic relationship of S aggregation, we constructed a Recombinant Inbred Line (RIL) panel derived from a cross between genetically divergent strains C. elegans NL5901 and SCH4856, both harboring the human S gene. As a first step to discover genetic modifiers 70 S-RILs were measured for whole-genome gene expression and expression quantitative locus analysis (eQTL) were mapped. We detected multiple eQTL hot-spots, many of which were located on Chromosome V. To confirm a causal locus, we developed Introgression Lines (ILs) that contain SCH4856 introgressions on Chromosome V in an NL5901 background. We detected 74 genes with an interactive effect between S and the genetic background, including the human p38 MAPK homologue pmk-1 that has previously been associated with PD. Together, we present a unique S-RIL panel for defining effects of natural genetic variation on S pathology, which contributes to finding genetic modifiers of PD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- C. elegans genetic background modifies the core transcriptional response in an α-synuclein model of Parkinson’s disease
Yiru A. Wang, Basten L. Snoek, … Simon Crawford Harvey·BMC GenomicsPeer-reviewed·Mar 20, 2019
- Single cell eQTL mapping reveals convergent glial-neuronal risk architecture in Parkinson's disease
Zechuan Lin, Jacob Parker, … Clemens R. Scherzer·bioRxiv·Apr 29, 2026
- Machine learning identifies six genetic variants and alterations in the Heart Atrial Appendage as key contributors to PD risk predictivity.
Daniel Ho, William S. Schierding, … Justin Martin O'Sullivan·Frontiers in GeneticsPeer-reviewed·Jan 3, 2022
- Label-Free Proteomics of α-Synuclein-Expressing Caenorhabditis elegans Model Uncovers Conserved Pathophysiological Pathways in Parkinson's Disease
Iverson Conrado Bezerra, Marc Vitorino, … Priscila Gubert·bioRxiv·Sep 23, 2026
- Loss of one Engrailed1 allele enhances induced α-synucleinopathy
Diptaman Chatterjee, Daniel Saiz‐Sánchez, … Patrik Brundin·Journal of Parkinson s DiseasePeer-reviewed·Mar 29, 2019
- Integration of eQTL and Parkinson’s disease GWAS data implicates 11 disease genes
Demis A. Kia, David Zhang, … Nicholas William Wood·bioRxiv·May 5, 2019